Since the CRISPR genome editing technology was invented in 2012, it has shown great promise to treat a number of intractable diseases. However, scientists have struggled to identify potential off-target effects in therapeutically relevant cell types, which remains the main barrier to moving therapies to the clinic. Now, a group of scientists have developed a reliable method to do just that.
from Top Technology News -- ScienceDaily https://www.sciencedaily.com/releases/2019/04/190419103657.htm
from Top Technology News -- ScienceDaily https://www.sciencedaily.com/releases/2019/04/190419103657.htm
Comments
Post a Comment
Thank you for your message. We are improving our services everyday.